PrimeRFP SCOUT · Federal Contract Recompete Brief

W91YTZ25FA113DRUG testing supplies - benzodiazepine FTDTL — Microgenics Corp

Microgenics Corp holds $4.3M across 166 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 3 related awards under parent N6264523D5009. PoP ended Aug 15, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W40m Mrco East

Awarding office

Microgenics Corp

Recipient

Aug 15, 2025

PoP end

$117K

Obligated

$117K

Potential

334516

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Microgenics Corp — $90

Contract facts

Federal

Contract numberW91YTZ25FA113

Also listed asN6264523D5009-W91YTZ25FA113

AgencyW40m Mrco East

Awarding officeW40m Mrco East

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentMicrogenics Corp

CAGE1MRF6

UEIE7WGWEK19Y79

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264523D5009

Place of performanceFORT GEORGE G MEADE MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMay 1, 2025

PoP end (current)Aug 15, 2025

Obligated$117K

Current value$117K

Potential value$117K

DRUG TESTING SUPPLIES - BENZODIAZEPINE FTDTL FORT MEADE, MD is a federal award for W40m Mrco East held by Microgenics Corp. Estimated value $117K ($117K obligated). Current period of performance ends Aug 15, 2025. Place of performance: FORT GEORGE G MEADE MD.

DRUG TESTING SUPPLIES - BENZODIAZEPINE FTDTL FORT MEADE, MD

Recompete timing

Public

● Past PoP end (371 days ago)

Current PoP ended Aug 15, 2025 (371 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Microgenics Corp — $4.3M obligated across 166 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($4.3M) · all agencies

Department of Defense (DOD)$3.9M · 91%Department of Veterans Affairs (VA)$411K · 10%

Open full company profile →

Related awards

Same parent · incumbent

36C26326N0005

TOXICOLOGY REAGENTS - MODIFICATION TO ADD A LINE ITEM TO THE BASE YEAR AND EACH OPTION YEA…

$165K

Sep 30, 2026

W81K0226FA033

BENZODIAZEPINE REAGENT KITS FOR TRIPLER ARMY MEDICAL CENTER (TAMC), HAWAII.

$164K

Oct 15, 2026

FA301626F0056

BENZODIAZEPINE REAGENT KITS

$176K

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W91YTZ25FA113?

W91YTZ25FA113 (DRUG testing supplies - benzodiazepine FTDTL) is a W40m Mrco East award with a potential value of $117K, currently held by Microgenics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W91YTZ25FA113?

W40m Mrco East awarded W91YTZ25FA113 to Microgenics Corp (potential $117K).

Who is the incumbent on W91YTZ25FA113?

Microgenics Corp is the incumbent with $4.3M across 166 related awards in SCOUT’s public footprint. The current period of performance ends Aug 15, 2025.

When does Microgenics Corp’s W91YTZ25FA113 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 15, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Apr 24, 2025